FDA-Approved GLP-1 Medications for Weight Loss FDA-approved GLP-1 receptor agonists used for chronic weight management include Wegovy, which contains semaglutide, and Saxenda, which contains liraglutide
The injectable medication is designed for long-term use, with Zepbound intended for ongoing treatment alongside a reduced-calorie diet and increased physical activity including aerobic exercise
The researchers suggest that changes in gut microbiome composition, particularly involving Akkermansia muciniphila and Parabacteroides distasonis , may explain the effects on GLP-1 and other gut-brain signaling molecules
GLP-1 receptor activation improves cell function and survival following induction of endoplasmic reticulum stress
But tirzepatide should not be used as a substitute for prescribed blood pressure medication unless a healthcare provider makes that change
Daily oral orforglipron, a nonpeptide GLP-1 receptor agonist, was associated with weight reduction [30] [31], offering potential advantages regarding administration route and patient convenience